Market Newsdesk

SAN FRANCISCO, Sept. 29, 2026 (GLOBE NEWSWIRE) — Fluence Energy (NASDAQ: FLNC) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired Fluence securities between November 24, 2025 and September 16, 2026.

The suit follows a stream of unexpected earnings announcements that were apparently at odds with Fluence’s assurances that it was positioned to capitalize on surging demand for data centers, and which collectively wiped out roughly $3 billion of the company’s market capitalization.

National shareholders rights firm Hagens Berman continues its investigation into claims that Fluence violated the federal securities laws.

The firm urges Fluence investors who suffered substantial losses to submit your losses now. In addition, persons with knowledge who may be able to assist the investigation are invited to contact the firm’s attorneys.

Class Period: Nov. 24, 2025 – Sept. 16, 2026
Lead Plaintiff Deadline: Nov. 27, 2026
Visit:www.hbsslaw.com/FLNC
Direct Contact Email: [email protected]
Firm Telephone: 844-916-0895
Blog: www.hbsslaw.com/blog/grid-scale-optimism-factory-scale-reality-fluence-energy-flnc

Fluence Energy, Inc. (FLNC) Securities Class Action:

The litigation’s focus is on the propriety of Fluence’s assurances that it was “well positioned to capitalize on the accelerating demand for energy storage[,]” and its backlog sufficiently covered revenue expectations. The company’s plan depended on successfully ramping its “fully automated” Houston manufacturing facility’s production of thermal management systems for its Gridstack ProTM battery energy storage solutions.

The complaint alleges that Fluence did not disclose important information to investors – its ability to deliver on its backlog and recognize revenue depended on new contract facilities that included incomplete and non-operational facilities. The complaint also alleges the company did not disclose that facility remediation efforts were unsuccessful.

Investors began to learn the truth through a series of partial disclosures beginning on February 4, 2026. That day, Fluence reported its Q1 2026 results included a significant year-over-year margin compression due to “additional estimated costs on two projects[]” and a significant year-over-year increase in net losses.

Then, on August 5, 2026 Fluence announced its Q3 2026 results included weaker than expected revenues, a massive year-over-year margin compression, and a net loss of $44.3 million compared to net income of $6.2 million in the same quarter last year.

The company said it “now expects that $400 million in project deliveries will be delayed into fiscal 2027 due to production issues at a new international contract facility[]” and also blamed “construction related delays that affected the completion and start-up of a new U.S. contract manufacturing facility.”

Finally, on September 16, 2026 Fluence slashed its 2026 revenue guidance again (by 20%). CEO Julian Nebreda Marquez blamed the continuing “delays in the ramp up of our contract manufacturing facility in Houston.” He also revealed the ramp delay was caused by having to manually weld rather than employing the automated welding process.

Each of these revelations triggered sharp declines in the price of Fluence shares. Between the first partial disclosure on February 4 and September 17, 2026 shares have fallen $21.33 (-73%).

“We’re focused on when the Houston welding issue was first known to Fluence management given the facility’s crucial role in onshoring,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Fluence and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding Fluence should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]

New York, Sept. 29, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib” or “the Company”) (Nasdaq: NAMM), today announced that Bulawayo Mining Company (Private) Limited, a wholly owned subsidiary of the Company, has secured a non-dilutive new term loan facility for US$ 6.5 million (the “New Term Loan Facility”) with African Banking Corporation of Zimbabwe Limited (“BancABC”). The New Term Loan Facility is in addition to the Company’s existing term loan and overdraft facilities with BancABC, with all such facilities consolidated into a single facility (the “Facility”). The Facility strengthens the Company’s liquidity and working capital position with the funds from the New Term Loan Facility earmarked for utilisation towards Step 3 of the Company’s Development Timelines and Milestones for Redwing Mine previously announced in July 2026 (the “Development Milestones”).

On September 21, 2026, the Company announced the completion of Step 1 of the Development Milestones, namely, dewatering at Redwing Mine ahead of schedule. Step 2 of the Development Milestones, being the Definitive Feasibility Study (“DFS”) technical programme, is presently underway and fully funded. Accordingly, the Facility builds on the funding presently secured and is expected to partially fund Step 3 of the Development Milestones, which includes surface exploration drilling and advancing the DFS to full bankability. Step 3 is designed to upgrade and extend the resource base and provide the geological foundation for the bankable feasibility study. The balance of Step 3 funding is expected to be provided under the Company’s sequenced financing plan, on which the Company will update the market in due course. 

“The continued support of Banc ABC reflects confidence in our operating platform at How Mine and in the disciplined, staged approach we have set out for the Redwing Mine restart,” said Sphe Mchunu, Company’s Chief Financial Officer. “This Facility funds the start of resource definition drilling at Redwing Mine without any dilution to existing shareholders; strengthens our liquidity position and keeps us on the milestone schedule we published in July. We continue to advance the remaining stages of our sequenced, non-dilutive financing plan in a disciplined manner.”

About Namib Minerals

Namib Minerals (NASDAQ: NAMM) is a gold producer, developer and explorer with operations focused in Zimbabwe. Currently Namib Minerals operates the How Mine, an underground gold mine in Zimbabwe, and aims to restart two assets in Zimbabwe. For additional information, please visit namibminerals.com. 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, without limitation, statements that refer to planned restart of Redwing Mine; the Company’s ability to carry out the various steps set forth in the Development Milestones; expected deployment of proceeds from the BancABC Facility; the Company’s ability to secure additional funding, including balance of the funding for Step 3 of the Redwing restart pathway; anticipated employment, procurement and production benefits; and the Company’s broader growth strategy. Forward-looking statements are typically identified by words such as “expects,” “intends,” “plans,” “targets,” “anticipates,” “believes,” “will,” “may” and similar expressions. These statements are based on management’s current expectations and assumptions and are subject to significant risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results to differ materially from those expressed or implied, including, risks and uncertainties described in the Company’s filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. No assurance can be given that the milestones, funding or production targets described in this press release will be achieved within the expected timeframes, or at all.

Contact:

Investor Relations:
[email protected] 

EVERETT, Wash., Sept. 29, 2026 (GLOBE NEWSWIRE) — Coastal Community Bank (the “Bank”, “Coastal”, “our”, “we”) has earned the silver award in the Best Bank category of the Seattle Times’ Best in the PNW program. The recognition reflects the relationships at the heart of our work—our customers, community partners, and dedicated employees. Every day, we strive to be more than a place to bank by helping local businesses grow, supporting community initiatives, and investing in the places we call home.

Beyond this recognition, Coastal Community Bank remains dedicated to making a meaningful difference in the communities it serves through volunteer efforts, financial education, support for the people we serve, and charitable giving.

“We are proud of this recognition, and even prouder of the work our team does to make a difference in our communities,” said Chris Adams, Executive Chair of the Corporation.

Coastal Community Bank is proud to announce the award of $48,500 in impact grants to six nonprofit organizations serving Snohomish and King counties. The funding will support programs that advance financial education, workforce development, affordable housing, and basic needs assistance, while also providing critical resources for women and children experiencing homelessness. Through these investments, the Bank continues its commitment to strengthening communities and expanding opportunities for those most in need.

Coastal Community Bank employees have participated in more than ten fundraising events in the past two weeks, supporting the important work of nonprofits in our community.

The Coastal Rack Pack team will be participating in the Making Strides Against Breast Cancer walk on October 24 in Everett. Visit the website to sign up for or donate to the walk.

“Community banking remains at the heart of who Coastal is,” Adams said. “We’re grateful for the opportunity to support local businesses, work alongside our nonprofit partners, and invest in the places we call home.”

About Coastal Financial

Coastal Financial Corporation (Nasdaq: CCB) (the “Company”), is an Everett, Washington based bank holding company whose wholly owned subsidiaries are Coastal Community Bank (“Bank”) and Arlington Olympic LLC.  The $5.46 billion Bank provides service through 14 full-service branches in Snohomish, Island and King Counties, one loan production office in King County, the Internet and its mobile banking application. The Bank provides banking as a service to digital financial service providers, companies and brands that want to provide financial services to their customers through the Bank’s CCBX segment. To learn more about the Company visit www.coastalbank.com. 

Contact


Chris D. Adams, Executive Chair of Coastal Financial Corporation, [email protected]
Eric Sprink, Chief Executive Officer, [email protected]
Joel G. Edwards, Chief Financial Officer, [email protected]

Forward-Looking Statements


This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. Any statements about our management’s expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Any or all of the forward-looking statements in this earnings release may turn out to be inaccurate. The inclusion of or reference to forward-looking information in this earnings release should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. We have based these forward looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to effectively evaluate and manage counterparty risk associated with CCBX partners and the risk that the conflicts in the Middle East and/or changes in U.S. trade policies, including the imposition of tariffs and retaliatory tariffs, may adversely impact our business, financial condition, and results of operations and those other risks and uncertainties discussed under “Risk Factors” in our Annual Report on Form 10-K for the most recent period filed and in any of our subsequent filings with the Securities and Exchange Commission.

If one or more events related to these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may differ materially from what we anticipate. You are cautioned not to place undue reliance on forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as required by law.

MIAMISBURG, Ohio, Sept. 29, 2026 (GLOBE NEWSWIRE) — Accelevation Holdings Corp. (“Accelevation”) today announced the pricing of its initial public offering of 30,000,000 shares of its Class A common stock at a public offering price of $18.00 per share, including 10,000,000 shares offered by Accelevation and 20,000,000 shares offered by certain selling stockholders affiliated with Olympus Partners. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 4,500,000 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions.

The shares of Class A common stock are expected to begin trading on The Nasdaq Global Select Market on September 30, 2026 under the ticker symbol “ACCV.” The offering is expected to close on October 1, 2026, subject to customary closing conditions.

Accelevation intends to use the net proceeds from the offering to purchase newly issued units in Accelevation Holdings LLC. In turn, Accelevation Holdings LLC intends to apply the balance of the net proceeds it receives from Accelevation to repay indebtedness, pay expenses incurred in connection with the offering and certain organizational transactions and for general corporate purposes. Accelevation will not receive any of the proceeds from the sale of shares of Class A common stock by the selling stockholders.

Morgan Stanley and J.P. Morgan are acting as joint lead bookrunning managers for the proposed offering. Goldman Sachs & Co. LLC, Barclays and BofA Securities are acting as joint bookrunning managers. Houlihan Lokey, Baird, William Blair, Piper Sandler and Wolfe | Nomura Alliance are acting as additional bookrunners.

The initial public offering is being made only by means of a prospectus. Copies of the final prospectus relating to the offering, when available, may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the final prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at [email protected].

A registration statement relating to the securities sold in the initial public offering has been filed with, and declared effective by, the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Accelevation

Accelevation is a leading designer, manufacturer and installer of customized structural, electrical and mechanical systems for mission-critical infrastructure. Its vertically integrated model combines U.S.-based manufacturing and nationwide field service capabilities to move customers faster from design through deployment with innovative, factory-built solutions engineered for speed, scalability and certainty. Accelevation solves complex needs at scale while investing in its communities, growing the skilled trades and creating opportunities for people to build lasting careers and share in the value they create. Accelevation’s principal executive offices are located at 9555 N. Springboro Pike, Suite 400, Miamisburg, Ohio 45342, and its telephone number is (937) 258-0616.

About Olympus Partners

Olympus Partners is a private equity firm focused on providing equity capital for middle market management buyouts and for growing companies. Olympus manages in excess of $12 billion mainly on behalf of pension funds, endowment funds and state-sponsored retirement programs. Founded in 1988, Olympus is an active, long-term investor across a broad range of industries including industrial and business services, food services, healthcare services, financial services, consumer and manufacturing.

For further information:

Investor Relations Contact:
Larry De Maria
[email protected]
+1 (937) 560-1133

Media Contact:
Chandler Martin
[email protected]
+1 (937) 802-2931

MCLEAN, Va., Sept. 29, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII), America’s largest military shipbuilder and the global leader in autonomous seapower, was awarded a contract by the U.S. Navy to build 10 ROMULUS unmanned surface vessels (USVs) for the Medium Unmanned Surface Vessel (MUSV) program. The award marks a major advancement in the U.S. Navy’s transition from experimentation to fleet-scale deployment of trusted, operational autonomy across the maritime domain.

“HII has made deliberate, early investments in the development of autonomous systems, advancing capabilities essential to the Navy’s hedge strategy,” said Chris Kastner, HII president and CEO. “We remain firmly committed to supporting the U.S. Navy’s vision and accelerating this critical capability from production to operational deployment.”

The U.S. Navy’s selection underscores HII’s shipbuilding expertise and leadership in proven autonomous unmanned surface and underwater maritime systems to deliver reliable production at the speed and scale required for emerging unmanned fleet production and operations.

Photos accompanying this release are available at: https://www.hii.com/news/hii-wins-us-navy-contract-for-10-romulus-usvs-accelerating-deployment-of-proven-autonomous-capability.

At the core of ROMULUS is HII’s Odyssey Autonomous Control Solutions (ACS), a combat-tested autonomy suite that enables trusted, coordinated operations across surface and undersea domains. HII has delivered more than 750 REMUS unmanned underwater vehicles (UUVs) to customers in more than 30 countries. Together, ROMULUS, REMUS and Odyssey ACS provide a scalable foundation for autonomous maritime operations supporting the U.S. Navy and allied fleets.

In 2025, HII committed to securing the partners, production capacity, supplier network and infrastructure needed to move quickly from design and development to construction of ROMULUS USVs. That investment reflected HII’s continued support of the U.S. Navy’s unmanned maritime priorities and advancing the unmanned surface program with mature technology and a production-ready approach. By beginning work in 2025, HII positioned the ROMULUS program for accelerated delivery, reduced production risk and to provide the U.S. Navy with a scalable path to fielding autonomous unmanned surface capabilities at the pace the nation demands.

“Unmanned vessels ultimately must be built, integrated, tested and sustained as part of a fleet,” said Andy Green, president of HII’s Mission Technologies division. “As the nation’s largest shipbuilder, HII understands that challenge from both sides. By pairing our advanced cutting-edge technologies with our shipbuilding expertise, and leveraging experienced regional partners and suppliers, we are creating a production ecosystem capable of delivering reliable autonomous platforms at the pace and scale the U.S. Navy requires.”

Odyssey ACS: The Autonomy Behind ROMULUS

A key differentiator of ROMULUS is HII’s Odyssey ACS, a modular, open-architecture autonomy suite developed from decades of experience designing, building, operating and sustaining unmanned maritime systems.

Odyssey is designed to deliver consistent, predictable autonomous behavior, a requirement for the U.S. Navy’s transition from experimentation to operational deployment. It provides decision-making architecture that enables unmanned systems to perceive their surroundings, navigate, manage onboard systems and payloads, coordinate with other manned and unmanned platforms, and execute complex missions with limited human intervention.

Odyssey’s modular, open-architecture lets the U.S. Navy and allied partners rapidly integrate emerging sensors, command-and-control (C2) technologies and AI algorithms, ensuring ROMULUS remains upgrade-ready for evolving threat environments.

HII, with its partners Applied Intuition, Greenroom Robotics and Rodi Marine, successfully completed the evaluation phase of the MUSV program. HII’s Odyssey ACS vessel capabilities were validated through a series of operationally representative test events, demonstrating performance, reliability and mission readiness. The U.S. Navy-monitored testing took place in the Gulf of America over a 13-day period and evaluated the system under demanding, real-world operating conditions.

The most rigorous event was a long-endurance mission simulation. HII’s autonomy system successfully completed the full 420-nautical-mile mission over 28 hours, meeting all established success criteria and demonstrating the endurance and autonomous performance required for sustained maritime operations.

Designed and Built by Shipbuilders for Scale

For ROMULUS, HII is combining that expertise with a distributed production model that leverages regional shipbuilders and manufacturing partners. This approach expands available production capacity, strengthens the U.S. maritime industrial base and enables vessels to be produced efficiently and repeatedly as U.S. Navy demand grows.

HII is working with Gulf Coast build partners including Breaux Brothers Enterprises, Halimar Shipyard and Bayou Metal Supply & Manufacturing in Louisiana to support ROMULUS production, and developed in partnership with Beier Integrated Systems and Incat Crowther.

HII also recently announced a new10,000-square-foot expansion to increase the capacity of HII’s existing 40,000-square-foot unmanned manufacturing production campus capacity to build, develop and integrate advanced unmanned and autonomous maritime systems for both the REMUS family of UUVs and ROMULUS USVs.

The model allows major components and assemblies to be produced efficiently before final vessel integration, increasing throughput and creating a repeatable production architecture that can scale across the ROMULUS USV family.

About HII

HII is America’s largest shipbuilder, delivering the world’s most powerful ships and all-domain mission technologies, including unmanned systems, to U.S. and allied defense customers. HII is the largest producer of unmanned underwater vehicles for the U.S. Navy and the world.

With a more than 140-year history of advancing U.S. national security, HII builds and integrates defense capabilities extending from the core fleet to C6ISR, AI/ML, EW and synthetic training. Headquartered in Virginia, HII’s workforce is 45,000 strong. For more information, visit:

• HII on the web: https://www.HII.com/
• HII on Facebook: https://www.facebook.com/TeamHII
• HII on X: https://www.twitter.com/WeAreHII
• HII on Instagram: https://www.instagram.com/WeAreHII
• HII on LinkedIn: https://www.linkedin.com/company/wearehii

Contact:
Greg McCarthy
(202) 264-7126
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d8ad2654-8701-4404-beb0-d34b186ce8a4

Châtillon, France, September 29, 2026

DBV Technologies Announces Submission of Biologics License Ap
p
lication to U.S. FDA for the VIASKIN

^®

Peanut Patch in Children Aged 4-7 Years

• The BLA is supported by the results from the successful Phase 3 VITESSE trial – the largest immunotherapy clinical trial to date for this population. 
• DBV has requested Priority Review of the BLA.

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, today announced that the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the VIASKIN® Peanut Patch in children with peanut allergy aged 4 through 7 years.

DBV has requested Priority Review of the BLA. The FDA previously granted Breakthrough Therapy Designation to the VIASKIN® Peanut Patch.

“The submission of our BLA brings VIASKIN® Peanut Patch, a non-invasive, practical treatment option, one step closer to being available for children ages 4 through 7 living with peanut allergy, and marks a significant milestone in DBV’s transformation into a commercial organization,”
said Daniel Tassé, Chief Executive Officer of DBV Technologies.
“This BLA reflects years of rigorous clinical development, meaningful contributions from the entire food allergy community, and ongoing collaboration with the FDA. We are grateful for the Agency’s constructive engagement over the last few months and look forward to working closely with them during the review process.”

The VIASKIN® Patch uses epicutaneous immunotherapy (EPIT), an innovative, non-oral, non-injection approach to food allergy treatment that delivers small amounts of an allergen protein through the skin. By using the immune properties of the skin, the VIASKIN® Peanut Patch is designed to progressively desensitize children to peanut allergy.

The BLA is supported by the positive results from the VITESSE Phase 3 clinical trial of the VIASKIN® Peanut Patch in 654 children ages 4 through 7 years with peanut allergy. VITESSE is the largest immunotherapy clinical trial to date for this population.

About the VITESSE Study

VITESSE (NCT05741476) is a global Phase 3, randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of the VIASKIN® Peanut patch (250 µg) in children ages 4-7 years with peanut allergy. The study enrolled 654 children randomized 2:1 to receive either VIASKIN® Peanut Patch or placebo. Conducted at 86 sites across the United States, Canada, United Kingdom, Europe, and Australia, VITESSE represents the largest immunotherapy clinical trial for this patient population. The primary endpoint is the difference between the percentage of treatment responders in the active versus placebo group after 12 months of treatment. Following the 12-month double-blind period, children were given the option to continue into an open-label extension where all participants receive VIASKIN® Peanut Patch for up to a total of three years on treatment.

About DBV Technologies

DBV Technologies is a late-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV Technologies is currently focused on investigating the use of its proprietary VIASKIN® Patch technology to address food allergies, which are caused by a hypersensitive immune reaction and characterized by a range of symptoms varying in severity from mild to life-threatening anaphylaxis. Millions of people live with food allergies, including young children. Through epicutaneous immunotherapy (EPIT), the VIASKIN® Peanut Patch is designed to introduce microgram amounts of a biologically active compound to the immune system through intact skin. EPIT is a new class of non-invasive treatment that seeks to modify an individual’s underlying allergy by re-educating the immune system to become desensitized to allergen by leveraging the skin’s immune tolerizing properties. DBV Technologies is committed to transforming the care of people with food allergies. The Company’s food allergy programs include ongoing clinical trials of VIASKIN® Peanut Patch in toddlers (1 through 3 years of age) and children (4 through 7 years of age) with peanut allergy.

DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (DBV, ISIN code: FR0010417345) and the Company’s ADSs (each representing five ordinary shares) are traded on the Nasdaq Capital Market (DBVT – CUSIP: 23306J309).

For more information, please visit www.dbv-technologies.com and engage with us on X (formerly Twitter) and LinkedIn.

Forward Looking Statements

This press release may contain forward-looking statements and estimates, including statements regarding the therapeutic potential of VIASKIN® Peanut patch and EPIT, results of DBV’s clinical trials, DBV’s planned regulatory and clinical efforts including timing and results of communications with regulatory agencies, plans, timing and expectations with respect to priority review of the BLA for VIASKIN® Peanut Patch for children ages 4 through 7, and the ability of any of DBV’s product candidates, if approved, to improve the lives of patients with food allergies. These forward-looking statements and estimates are not promises or guarantees and involve substantial risks and uncertainties. At this stage, DBV’s product candidates have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, and DBV’s ability to successfully execute on its budget discipline measures. A further list and description of risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements in this press release can be found in DBV’s regulatory filings with the French Autorité des Marchés Financiers (“AMF”), DBV’s filings and reports with the U.S. Securities and Exchange Commission (“SEC”), including in DBV’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 26, 2026, as amended by Amendment No. 1 on Form 10-K/A filed with the SEC on April 30, 2026, DBV Technologies’ Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 filed with the SEC on April 30, 2026 and July 16, 2026, respectively, and future filings and reports made with the AMF and SEC by DBV. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof. Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release.

VIASKIN is a registered trademark of DBV Technologies.

Investor Relations Contact

Virginie Boucinha
DBV Technologies
[email protected]

Media Contact

Brett Whelan
DBV Technologies
[email protected] 

Attachment

• PDF Version

GRAND RAPIDS, Mich., Sept. 29, 2026 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2026 third quarter results on Tuesday, October 27, 2026, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website.

Brad Kessel, President and CEO, Gavin Mohr, CFO and Joel Rahn, EVP Commercial Banking will review the quarterly results in a conference call for investors and analysts beginning at 11:00 am ET on Tuesday, October 27, 2026.

To access via phone, participants will need to register using the following link where they will be provided a phone number and access code: https://register-conf.media-server.com/register/BI8251941b98524fec94bd98aeea90727e

In order to view the webcast and presentation slides, please go to https://edge.media-server.com/mmc/p/oko972r9 during the time of the call. A replay of the webcast will be available until October 27, 2027.

About Independent Bank Corporation

Independent Bank Corporation (NASDAQ: IBCP) is a Grand Rapids, Michigan-based bank holding company and the parent company of Independent Bank and, as of July 1, 2026, Highpoint Community Bank. Independent Bank Corporation has total assets of approximately $6.3 billion and operates from 66 locations across Michigan’s Lower Peninsula. Founded in 1864 as First National Bank of Ionia, Independent Bank provides a full range of financial services, including commercial banking, consumer banking, mortgage lending, and investment services. Independent Bank expects to complete the full system integration of Highpoint Community Bank’s operations on November 9, 2026. Until conversion, customers of Highpoint Community Bank should continue using their existing Highpoint Community Bank branches, checks, bank cards, online and mobile banking, and other banking services as usual.

For more information, please visit our website at: IndependentBank.com.

BIRMINGHAM, Ala., Sept. 29, 2026 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc. (NYSE: SFBS) is scheduled to announce earnings and operating results for the quarter ended September 30, 2026 on October 19, 2026 at 4 p.m. ET. The news release will be available at www.servisfirstbancshares.com.

ServisFirst Bancshares, Inc. will host a live audio webcast to discuss earnings and results on Monday, October 19, 2026 beginning at 5:15 p.m. ET. The audio webcast can be accessed at www.servisfirstbancshares.com. A replay of the call will be available until October 31, 2026.

About
ServisFirst
Bancshares,
Inc.

ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Alabama, Florida, Georgia, North and South Carolina, Tennessee, Texas, and Virginia. Through the bank, we originate commercial, consumer and other loans and accept deposits, provide electronic banking services, such as online and mobile banking, including remote deposit capture, deliver treasury and cash management services and provide correspondent banking services to other financial institutions.

ServisFirst Bancshares, Inc. files periodic reports with the U.S. Securities and Exchange Commission (SEC). Copies of its filings may be obtained through the SEC’s website at www.sec.gov or at www.servisfirstbancshares.com.

More information about ServisFirst Bancshares, Inc. may be obtained over the Internet at www.servisfirstbancshares.com or by calling (205) 949-0302.

Contact: ServisFirst Bank
Davis Mange (205) 949-3420
[email protected]